BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye’s AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors

  Adlai Nortye Ltd. today announced that it has entered into a clinical collaboration with Merck (known as MSD outside the US and Canada) to evaluate the combination of Adlai Nortye’s AN0025 (EP4 Antagonist) and Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in patients with solid tumors.

  January 3, 2019

   · 

  2 min read
• ProBioGen’s GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals

  Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology

  January 3, 2019

   · 

  3 min read
• Biotech Bay

  Gynesonics Announces $75 Million Financing

  Equity Round led by Bain Capital Life Sciences

  January 3, 2019

   · 

  5 min read
• New Research From The University of Liverpool and WALTHAM Reveals Overweight Dogs May Live Shorter Lives

  Study of over 50,000 dogs across 12 breeds shows link between a dog’s weight and expected lifespan

  January 3, 2019

   · 

  6 min read
• Job Trends

  Caris Life Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference

  Caris Life Sciences® announced today that David D. Halbert, Chairman and Chief Executive Officer, will present at the 2019 J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, at 11 a.m. PST (2 p.m. EST) at the Westin St. Francis Hotel in San Francisco.

  January 3, 2019

   · 

  1 min read
• Global Sarcoma Therapeutics Market 2019-2023| Advent of Regenerative Medicine to Drive Growth| Technavio

  Technavio’s global sarcoma therapeutics market research report forecasts the market to grow at a CAGR of over 8% during the forecast period.

  January 3, 2019

   · 

  4 min read
• Business

  IRRAS Enters Into Global Partnership With HealthLink to Support Distributors of IRRAS’ Medical Products

  IRRAS AB today announced that it has entered into a partnership with HealthLink Europe & International to serve as IRRAS’ global logistics and customer service partner.

  January 3, 2019

   · 

  3 min read